Breaking News

You are here » Indian-Commodity  :  Economy  :  India's pharma exports declined by 4% till August on pricing pressure

10-Oct2017

India's pharma exports declined by 4% till August on pricing pressure

India's pharmaceutical exports has registered a negative growth of 4 percent during the first five months of the financial year 2017-18, mainly due to increased regulatory issues along with pricing pressure in global markets. Udaya Bhaskar, the Director General of the Pharmaceuticals Export Promotion Council of India (Pharmexcil), has said that the pharma exports to other countries declined by 7.9 percent during the April-July period, while recovered to 4 percent in the month of August leaving the overall growth at minus 4 percent till August this year.

Bhaskar has pointed out that pricing pressure is one of the factors for decline in exports. He also noted that factors such as import alerts by US Food and Drug Administration (USFDA) on Indian plants, regulatory issues and currency fluctuation, also contributed to downward growth. However, he hoped that the overall exports will recover and come into positive zone for the full year as exports are expected to take an uptick from September.

Pharmexcil's Director General further said that initially, rollout of Goods and Services Tax (GST) regime also created some confusion among the manufacturers leading to stoppage of production by some companies, but now they are seeing some growth. According to statistics, India exported $16.90 billion worth of pharma products during 2015-16 and the same was slightly declined to $16.64 billion in 2016-17.


Related News

View all news

Job creation trebles in February to reach 8.61 lakh: EPFO

The Retirement fund body, Employment Provident Fund Organisation (EPFO) in its latest 'Net Payroll Data' report has showed that job creation in India's formal sector almost trebled to 8.61 lakh in February......

Reform process in India must be completed in coming five years: Arvind Panagariya

In order to create decent jobs for the masses as well as give serious thought to privatising the public sector banks (PSBs), Arvind Panagariya, who had served as the first Vice Chairman of the NITI Aayog......

P-notes investment jumps to Rs 78,110 crore at March-end

With positive market sentiments, the share of foreign portfolio investments (FPI) in domestic capital markets through participatory notes (P-notes) jumped to Rs 78,110 crore at the end of March. According......

Top News

View all news

Bank of Baroda's board to consider issuance of equity shares of Rs 5,042 crore to Govt

Bank of Baroda's board is going to consider issuance of equity shares of Rs 5,042 crore to Government of India on a Preferential Basis. The meeting of the Board of Directors of the Bank is scheduled to......

Gujarat Petrosynthese to invest surplus funds in mutual funds, bonds, securities, shares

Gujarat Petrosynthese has received an approval to invest surplus funds in mutual funds, bonds, securities, shares, inter corporate deposits etc. to optimize its returns. The Board of Directors of the Company......

Reliance's Retail Unit delivers record-breaking performance in revenue, profits during FY19

Reliance Industries' Retail Unit--Reliance Retail has delivered a record-breaking performance in revenue and profits growth for the year 2018-19. Segment Revenue for FY19 grew by 88.7% Y-o-Y to Rs 130,566......